The Osmanbeyoglu Lab (osmanbeyoglulab.com) is seeking enthusiastic postdoctoral scholars in Computational Biology and Machine Learning. The successful candidate will develop integrative statistical and machine learning approaches for extracting insights from cutting-edge multi-omic single cell datasets (CITE-seq, scATAC-seq, spatial transcriptomics) as well as clinical and drug response data for the purpose of precision cancer therapy.
The Osmanbeyoglu Lab is a rapidly growing, NCI-funded multi-disciplinary hybrid wet/dry lab at the University of Pittsburgh. We are affiliated with the Department of Biomedical Informatics, Bioengineering and UPMC Hillman Cancer Center. Our group is fortunate to have the necessary combination of large clinical sample volume at UPMC Hillman Cancer Center, single-cell technology and computational biology experience. The University consistently ranks in the top 5 nationally for NIH biomedical research funding and the Cancer Center was recently ranked #7 by US News & World Report. Pittsburgh, PA is often voted the most livable city in the US featuring eclectic neighborhoods, diverse culinary and entertainment opportunities, as well as accessible outdoor recreation (www.coolpgh.pitt.edu/).
Salary: $65,000 per year
Benefits: standard employee with outstanding health benefits
PhD in applied quantitative discipline, such as computational biology, bioinformatics, biostatistics, mathematics or computer science with a strong interest in translational biomedical research. Ideal candidates would have publications demonstrating experience with code development, applied mathematics, machine learning, deep learning and/or computational biology. The candidate should 1) be able to work independently and as a member of a team, and 2) be hard-working, motivated, and eager to learn with an outstanding work ethic.
If interested, please send an email to Dr. Osmanbeyoglu (osmanbeyogluhu @ pitt dot edu) and include your CV (with references) and research interests. Please put the words “POSTDOC-APPLICATION-2020” in the subject line.